Close

Hemispherx Biopharma (HEB) to Offer $5M in Common Stock in Registered Direct Offering

August 31, 2016 8:32 AM EDT Send to a Friend
Hemispherx Biopharma, Inc. (NYSE: HEB) announced today that it has entered into definitive agreements with two healthcare focused institutional investors ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login